PATENT CLAIM ANALYSIS

Application Number: 15872864
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "414000"]

Abstract:
A method for identifying an increased risk of developing ST-Segment Elevation Myocardial Infarction (STEMI) in a subject involves obtaining a platelet-containing plasma sample from the subject; determining a Prostaglandin E2 (PGE2) phenotype of the platelets of the subject; and identifying the subject has having an increased risk of developing STEMI when the subject has a potentiating phenotype, as compared to the risk of a subject having an inhibitory phenotype.

Claim (Index 2):
The method of  claim 1 , and when the subject has a potentiating phenotype, further comprising:\n (a) contacting a third portion of the plasma sample with an EP3 antagonist and the thromboxane agonist; (b) contacting a fourth portion of the plasma sample with the EP3 antagonist, the thromboxane agonist, and PGE2; (c) comparing the platelet aggregation in the third portion of the plasma sample to the platelet aggregation in the fourth portion of the plasma sample; and (d) determining whether the potentiating phenotype has shifted to an inhibitory phenotype.

Metadata:
- Claim Count in Document: 34.0
- Percentile: 86.0
- Lexical Diversity: 1.75
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13937011', '13774516', '12037012', '14233876', '11304054']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7052346346564923
- 35 USC 102 Novelty (BERT): 0.530141636130238
- Combined Prediction Score: 0.6877253348038669
- Mean Citation Score: 223.476902
- Max Citation Score: 321.02414
- Similarity Product: 214.33132195591327

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test